Gut microbiome in IgA and membranous nephropathy, case-control
61 samples from a case-control study comparing gut microbiota and metabolomic profiles among IgA nephropathy patients, membranous nephropathy patients, and healthy controls; sample location not reported. machine-written summary
61 samples · 61 runs · CN · Age unknown · 2026 · 6.41 Gbp / sample
Checked this project's papers and archive records yourself? Mark it human-verified.
what each source gave
| ✓ Sequence archive | 61 sample values (collection date) |
| ○ Abstract / description | read; no usable statement |
| ✓ Full text | 122 sample values (country, subject id) · PMC12307357 |
| ○ Supplementary tables | files read; no table could be matched to the samples |
| – External resources | not covered by the external resources we ingest |
| – User contribution | nothing uploaded yet · share metadata |
| – Human verified | not yet checked by a person · I checked this project — verify it |
No Sandpiper profile for this project's samples yet.
| field | samples | coverage | R1 | R2 | R3 | R4 |
|---|---|---|---|---|---|---|
| age_category | 0 | 0% | ||||
| country | 61 | 100% | 61 | |||
| health_condition | 0 | 0% | ||||
| subject_id | 61 | 100% | 61 | |||
| collection_date | 61 | 100% | 61 |
- The dysbiosis of gut microbiota and dysregulation of metabolites in IgA nephropathy and membranous nephropathy. 2025 PMID 40740937 PMC12307357 own_data
Archive description
Immunoglobulin A nephropathy (IgAN) and membranous nephropathy (MN) are primary glomerular diseases with increasing incidence, yet their pathogenesis and non-invasive diagnostic approaches remain insufficiently understood. In this study, we integrated metagenomic and untargeted metabolomic profiling to explore gut microbiota alterations and metabolic disturbances in 24 IgAN patients, 20 MN patients, and 17 healthy controls.
How this project entered the registry
Classified as human gut / stool shotgun DNA metagenome of age unknown by sonnet_x2 with confidence 0.68. Assay shotgun_dna.
- host run.scientific_name · “human gut metagenome”
- body site run.scientific_name · “human gut metagenome”
Evidence examples (one per field × route)
| sample | field | value | route | conf. | source | quote |
|---|---|---|---|---|---|---|
| SAMD01841713 | collection_date | 2024-04-15 | R1 | 0.90 | biosample.attribute:collection_date | 2024-04-15 |
| SAMD01841713 | country | CN | R3 | 0.70 | paper.body.methods_results | A total of 61 subjects from Guang’an First People’s Hospital, Sichuan Province, China, were enrolled in this study. |
| SAMD01841713 | subject_id | SAMD01841713 | R3 | 0.70 | design.one_sample_per_subject:fulltext | A total of 61 subjects from Guang’an First People’s Hospital, Sichuan Province, China, were enrolled |
Sequencing
61 runs over 61 samples · mean 6.52 Gbp per run (median 6.41 Gbp, total 397.43 Gbp; 61 runs with a base count) · layout PAIRED 61 · platform ILLUMINA 61 · models Illumina NovaSeq 6000 (61) · 0% of runs with a Sandpiper profile · first public 2026-06-02
Authors (0)
No author record.
Help complete this project
2 of the 4 core fields are below 50% coverage: age_category, health_condition. Share metadata
Downloads
PRJDB37437.csv.gz (2.6 KB) · parquet (71.4 KB) — all 61 samples, every field with route and confidence · PRJDB37437_determinations.csv.gz (2.2 KB) — 183 evidence rows